Back to Search
KEVAN HARTSHORN, M.D.
M.D.
Medical Oncology Physician
NPI: 1700862745IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
49999(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
49999(MA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1980
Research & Publications (20)
Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.
PMID 18811961·Respir Res·2008
8-other
Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D.
PMID 17280604·Respir Res·2007
8-other
Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D.
PMID 16709857·J Immunol·2006
4-observational
Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation.
PMID 16190864·Biochem J·2006
7-preclinical
Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication.
PMID 16227233·J Gen Virol·2005
8-other
Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses.
PMID 12871854·Am J Physiol Lung Cell Mol Physiol·2003
7-preclinical
Role of the respiratory burst in co-operative reduction in neutrophil survival by influenza A virus and Escherichia coli.
PMID 12018655·J Med Microbiol·2002
8-other
Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria.
PMID 12379690·Infect Immun·2002
7-preclinical
Distinctive anti-influenza properties of recombinant collectin 43.
PMID 11971759·Biochem J·2002
7-preclinical
Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity.
PMID 11023831·Biochem J·2000
7-preclinical
Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein.
PMID 10645895·Am J Physiol Lung Cell Mol Physiol·2000
7-preclinical
Development of chimeric collectins with enhanced activity against influenza A virus.
PMID 10897409·Adv Exp Med Biol·2000
6-review
Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.
PMID 19249874·Biochemistry·2009
8-other
Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.
PMID 19155475·J Immunol·2009
4-observational
Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.
PMID 19494312·J Immunol·2009
7-preclinical
Multiple components contribute to ability of saliva to inhibit influenza viruses.
PMID 19121065·Oral Microbiol Immunol·2009
8-other
Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.
PMID 18302538·Biochem J·2008
7-preclinical
Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus.
PMID 19017984·J Immunol·2008
7-preclinical
Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells.
PMID 17520282·Med Microbiol Immunol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 830 HARRISON AVE, MOAKLEY, 3RD FLOOR
BOSTON, MA 02118 - Phone
- (617) 638-6248
Quick Facts
- NPI
- 1700862745
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile